Healthcare Global Enterprises Limited (HCG), a leading provider of specialized oncology services in India, has announced its plans to expand its footprint in the African healthcare market. The company's Board of Directors has approved an investment of up to Rs. 700 lakhs (approximately $840,000) in Cancer Care Kenya Limited, a step-down subsidiary of HCG.

Investment Details

The investment, which is subject to applicable regulatory approvals and completion of necessary formalities, will be made in equity shares of Cancer Care Kenya Limited. The decision was made during the Board meeting held on November 12, 2023, and is based on the fair value of Cancer Care Kenya's shares as determined by an independent valuer.

Strategic Expansion

This move appears to be part of HCG's strategy to strengthen its presence in the African healthcare sector. Cancer Care Kenya Limited, which operates in Nairobi, Kenya, provides radiation and chemotherapy services, including a 15-bedded Day Care Centre.

Financial Performance of Cancer Care Kenya

Cancer Care Kenya has shown significant growth in recent years. For the financial year ended March 31, 2023, the company reported:

The company's revenue has shown substantial growth over the past three years:

Market Implications

This investment may signal HCG's confidence in the growth potential of the African healthcare market, particularly in oncology services. It also reflects the company's commitment to expanding its international presence and diversifying its revenue streams.

Regulatory Compliance

The investment is structured in compliance with applicable regulations, including those set by the Securities and Exchange Board of India (SEBI). HCG has stated that the proposed investment is subject to necessary regulatory approvals, indicating the company's adherence to cross-border investment norms.

Multi-Year Growth Strategy

In addition to its investment in Cancer Care Kenya, Healthcare Global Enterprises has outlined a comprehensive multi-year growth strategy. The strategy focuses on:

1. Oncology Expansion: The company plans to invest in new cancer centers across Tier-1 and Tier-2 cities, broadening its reach and service offerings.

2. Clinical Excellence: HCG aims to maintain and enhance its reputation for providing high-quality oncology care.

3. Regional Network Deepening: The strategy includes strengthening HCG's presence in existing markets while expanding into new regions.

4. Margin Improvement: The company expects strong margins, supported by high-occupancy hospitals and operational efficiency measures.

5. Precision Oncology: HCG is emphasizing the development and implementation of precision oncology techniques to improve treatment outcomes.

6. Digital Health Platforms: The company plans to leverage digital health technologies to enhance patient care and operational efficiency.

This multi-faceted approach demonstrates HCG's commitment to long-term growth and its ambition to strengthen its position as a leader in oncology services both in India and internationally.

As Healthcare Global Enterprises continues to expand its operations, the investment in Cancer Care Kenya, coupled with its comprehensive growth strategy, could potentially enhance its position in the growing African healthcare market and contribute to its long-term growth in specialized oncology services.

Multiple schemes of Motilal Oswal Mutual Fund have recently increased their collective stake in Healthcare Global Enterprises Ltd, a move that pushes their total shareholding above the 5% mark. This acquisition, completed on October 29, 2025, has been reported under SEBI substantial acquisition regulations.

Acquisition Details

The mutual fund schemes acquired an additional 1,54,556 shares of Healthcare Global Enterprises through market transactions. This strategic move has resulted in an increase in their collective holding from 4.93% to 5.04% of the company's total share capital.

Transaction Specifics

• Date of Acquisition: October 29, 2025
• Mode of Acquisition: Market Transactions
• Total Equity Share Capital: 14,10,00,100 shares (Face value of Rs. 10 each)

Participating Schemes

The acquisition was carried out by multiple schemes of Motilal Oswal Mutual Fund, including:

1. Motilal Oswal Balanced Advantage Fund
2. Motilal Oswal S And P BSE Healthcare ETF
3. Motilal Oswal Nifty Microcap 250 Index Fund
4. Motilal Oswal Multi Cap Fund
5. Motilal Oswal Business Cycle Fund
6. Motilal Oswal Infrastructure Fund
7. Motilal Oswal Active Momentum Fund
8. Motilal Oswal Special Opportunities Fund
9. Motilal Oswal BSE 1000 Index Fund
10. Motilal Oswal Services Fund
11. Motilal Oswal Consumption Fund

Regulatory Compliance

The transaction has been reported in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Motilal Oswal Asset Management Company Limited, as the investment manager to Motilal Oswal Mutual Fund, has duly informed the stock exchanges about this acquisition.

This move by Motilal Oswal Mutual Fund indicates their investment decision regarding Healthcare Global Enterprises, a company listed on both the BSE Limited and the National Stock Exchange of India Limited.